Comparison of Procalcitonin Assays on KRYPTOR and LIAISON® XL Analyzers

Diagnostics - Tập 9 Số 3 - Trang 94
Mariella Dipalo1, Cecilia Gnocchi1, Paola Avanzini1, Roberta Musa1, Martina Di Pietro1, Rosalia Aloe1
1SSD Biochimica ad Elevata Automazione, Azienda Ospedaliera Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy

Tóm tắt

Our laboratory performs procalcitonin (PCT) assays on a Brahms KRYPTOR analyzer with the Brahms PCT sensitive Kryptor kit. In this study, we wanted to compare the assays obtained in this way with the ones performed on the LIAISON® XL. From January to May 2017, 171 samples were analyzed, of which 65 from female patients (age: 22–98 years) and 106 from male patients (age: 16–97 years). The PCT determination was performed using the LIAISON® XL and KRYPTOR analyzers, by chemiluminescence (Chemiluminescence immunoassay—CLIA) (LIAISON® BRAHMS PCT® II GEN) and immunofluorescence (Brahms PCT sensitive Kryptor) assay, respectively. For the LIAISON® BRAHMS PCT® II GEN, 52% of the results were placed between 0.0 and 0.5 ng/mL, 18% between 0.5 and 2.0 ng/mL, and 30% between 2.0 and 100 ng/mL; the mean was 4.09 ng/mL, the median 0.456 ng/mL, the maximum value 97.2 ng/mL, and the minimum value 0.02 ng/mL. For the Brahms PCT sensitive Kryptor, 55% of the results were positioned between 0.0 and 0.5 ng/mL, 21% between 0.5 and 2.0 ng/mL, and 24% between 2.0 and 100 ng/mL; the mean was 3.72 ng/mL, the median 0.39 ng/mL, the maximum value 103 ng/mL, and the minimum value 0.01 ng/mL. The mean of the results obtained with the two methods showed no significant differences (3.717 for Kryptor and 4.094 for LIAISON®). PCT assay with Brahms reagents, both on the Kryptor and LIAISON®XL platforms, offers excellent performance in terms of sensitivity and specificity.

Từ khóa


Tài liệu tham khảo

Scicluna, 2017, The immunopathology of sepsis and potential therapeutic targets, Nat. Rev. Immunol., 17, 407, 10.1038/nri.2017.36

Veneziani, F., Fabrizia Petrucci Montanelli, C., Lombardelli, L., Anelli, M.C., and Casprini, P. (, January Octorber). Razionalizzazione e implementazione del dosaggio per la procalcitonina con metodo immunoturbidimetrico nell’USL Toscana Centro. Proceedings of the 50° Congresso Nazionale della Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC—Medicina di Laboratorio), Napoli, Italy.

Morgenthaler, 2003, Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection, Horm. Metab. Res., 35, 290, 10.1055/s-2003-41304

Lippi, 2019, The Irreplaceable Value of Laboratory Diagnostics: Four Recent Tests that have Revolutionized Clinical Practice, EJIFCC, 30, 7

Tan, 2019, The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis, J. Cell Biochem., 120, 5852, 10.1002/jcb.27870

Meier, 2018, Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: A patient-level meta-analysis of randomized trials, Clin. Infect. Dis., 69, 388, 10.1093/cid/ciy917

Zaman, 2017, A Review on Antibiotic Resistance: Alarm Bells are Ringing, Cureus, 9, e1403

(2019, February 01). ThermoFisher SCIENTIFIC Home Page. Available online: https://www.procalcitonin.com/pct-assays/pct-liaison.html.

(2019, February 01). ThermoFisher SCIENTIFIC Home Page. Available online: https://www.procalcitonin.com/pct-assays/pct-sensitive-kryptor.html.

Fortunato, 2016, A new sensitive automated assay for procalcitonin detection: LIAISONs BRAHMS PCTs II GEN, Pract. Lab. Med., 6, 1, 10.1016/j.plabm.2016.06.002

Lippi, 2018, Procalcitonin for diagnosing and monitoring bacterial infections: For or against?, Clin. Chem. Lab. Med., 56, 1193, 10.1515/cclm-2018-0312

Thông tin
Thông tin xuất bản

Diagnostics

Tập 9 Số 3

94

Thông tin tác giả